Viewing Study NCT01324960


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-05-02 @ 2:42 AM
Study NCT ID: NCT01324960
Status: WITHDRAWN
Last Update Posted: 2014-03-20
First Post: 2011-03-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes
Sponsor: Groupe Francophone des Myelodysplasies
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High risk View
None Azacitidine View
None Ceplene View
None IPSS View